Navigation Links
Vion Pharmaceuticals Regains NASDAQ Listing Compliance
Date:3/7/2008

NEW HAVEN, Conn., March 7 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq Capital Market: VION) today announced that it had received notification from NASDAQ that the Company had regained compliance with Marketplace Rule 4310(c)(4) since the closing bid price of its Common Stock had traded at $1.00 per share or greater for at least ten consecutive business days.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a unique alkylating agent, is being evaluated in a pivotal Phase II trial as a single agent in elderly patients with de novo poor-risk acute myelogenous leukemia. Clinical trials of Cloretazine(R) (VNP40101M) as a single agent in small cell lung cancer, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the potential inability to secure external sources of funding to continue operations,
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... said that nothing makes a lady feel more feminine than ... shows its new selection of navy cocktail dresses , ... navy cocktail gowns are the cornerstones of the site’s cocktail ... dresses in bright neon colors can be dressed up or ... those who want to shine among the crowd by wearing ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 The Biofeedback ... place March 24-28, 2015 in Rome, Italy and is ... includes workshops on a wide variety of ... well as peak performance training in athletes. The scientific ... the world. , Biofeedback monitoring allows clients to see ...
(Date:12/26/2014)... 2014 India Network Foundation, a non-profit ... USA, announced today a new version of “ EasySelect ... the right plan for their visiting parents. The technology ... the selection process when choosing an insurance plan by ... only a few clicks. Many elderly Asian Indian parents ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
Breaking Medicine News(10 mins):Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2
... led by the University of Kentucky researcher Elaine Wittenberg-Lyles ... themselves and require their own unique care needs. ... Qualitative Health Research , assessed the individual stressors that ... and the intervention team. The caregivers were asked to ...
... , WEDNESDAY, Nov. 30 (HealthDay News) -- Eating baked or ... brain health and lower the risk for mild cognitive impairment ... study authors found that eating baked and broiled fish -- ... strengthening them in areas of the brain deemed critical to ...
... Publicly posting enforcement and testing data corresponding to ... the Internet could have "substantial benefits," including the potential ... from the National Research Council. The report adds ... increased transparency and yield valuable insights that go beyond ...
... December issue of the FASEB Journal ( http://www.fasebj.org ... a simple blood test to detect Parkinson,s disease even at ... a substance in the blood, called "phosphorylated alpha-synuclein," which is ... way to identify its presence in our blood. "A ...
... as an important factor in determining the quality of ... change without significant cost and investment of resources. What,s ... more difficult for hospitals to increase nurse staffing. A ... Care Management Review indicates that there are other ...
... the nastiest smelling creatures on Earth have skin that ... hold promise for becoming new weapons in the battle ... amphibians so smelly (like rotten fish, for instance) that ... Journal of Proteome Research . Yun Zhang, Wen-Hui ...
Cached Medicine News:Health News:Study shows hospice caregivers need routine care interventions 2Health News:Non-Fried Fish Might Help Ward Off Alzheimer's: Study 2Health News:Non-Fried Fish Might Help Ward Off Alzheimer's: Study 3Health News:Publicly releasing inspection data on meat processing facilities could have 'substantial benefits' 2Health News:Publicly releasing inspection data on meat processing facilities could have 'substantial benefits' 3Health News:Simple blood test diagnoses Parkinson's disease long before symptoms appear 2Health News:Improving patient care by improving nurses' work environment 2
(Date:12/24/2014)... Dec. 23, 2014  Medical Science Liaisons play a ... link between the medical device industry and key stakeholders, ... the coming years as the device industry relies on ... to research by benchmarking firm, Best Practices, LLC, one ... important edge is by harnessing new technology to enable ...
(Date:12/22/2014)... , Dec. 22, 2014 NxStage ... manufacturer of innovative dialysis products, announced today that ... cleared its System One™ to perform hemodialysis overnight ... as home nocturnal hemodialysis. NxStage,s® System One is ... the FDA for this indication. ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "US Self-monitoring Blood Glucose Market" report to their ... This market insight focuses on the developments in ... United States . Reimbursement analysis and the effects ... for more than 73 SMBG meters have been performed, ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
5 mm curved blade. Round handle....
2 mm x 3 mm tapered blade. Referred to as "Number Two Knife". Angled 45 degrees. Round handle....
7 mm strong curved blade. Round handle....
Medicine Products: